1.     Surveillances V. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) − China, 2020. China CDC Weekly 2020; 2 (8): 113−22.

2.     Scappaticcio L, Pitoia F, Esposito K et al. Impact of COVID-19 on the thyroid gland: an update [published online ahead of print, 2020 Nov 25]. Rev Endocr Metab Disord 2020; 1−13. DOI: 10.1007/s11154-020-09615-z

3.     De Vito P, Incerpi S, Pedersen JZ et al. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid 2011; 21 (8): 879–90. DOI: 10.1089/thy.2010.0429

4.     Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev 1993; 14 (1): 107–20. DOI: 10.1210/edrv-14-1-107

5.     Петунина Н.А., Эль-Тарави Я.А., Суркова А.Ю., Мартиросян Н.С. Заболевания щитовидной железы и COVID-19. Доктор.Ру 2021; 20 (2): 6–10. DOI: 10.31550/1727-2378-2021-20-2-6-10

[Petunina N.A., Al Taravi Ya.A., Surkova A.Yu., Martirosyan N.S. Thyroid Disorders and COVID-19. Doctor.Ru 2021; 20 (2): 6–10. DOI: 10.31550/1727-2378-2021-20-2-6-10 (in Russian)].

6.     Franceschi C, Ostan R, Mariotti S et al. The aging thyroid: A reappraisal within the geroscience integrated perspective. Endocr Rev 2019; 40 (5): 1250–70. DOI: 10.1210/er.2018-00170

7.     Shih CH, Chen SL, Yen CC et al. Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 2004; 145 (6): 2804–14. DOI: 10.1210/en.2003-1372

8.     Davis PJ, Glinsky GV, Lin HY, Mousa SA. Actions of thyroid hormone analogues on chemokines. J Immunol Res 2016; 2016: 3147671. DOI: 10.1155/2016/3147671

9.     Ferrari SM, Fallahi P, Galetta F et al. Thyroid disorders induced by checkpoint inhibitors. Rev Endocr Metab Disord 2018; 19 (4): 325–33. DOI: 10.1007/s11154-018-9463-2

10. Scappaticcio L, Castellana M, Virili C et al. Alemtuzumab-induced thyroid events in multiple sclerosis: A systematic review and meta-analysis. J Endocrinol Invest 2020; 43 (2): 219–29. DOI: 10.1007/s40618-019-01105-7

11. Nishihara E, Ohye H, Amino N et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med 2008; 47 (8): 725–9. DOI: 10.2169/internalmedicine.47.0740

12. Akamizu T. Thyroid storm: A japanese perspective. Thyroid 2018; 28 (1): 32–40. DOI: 10.1089/thy.2017.0243

13. Davis PJ, Mousa SA, Schechter GP. New interfaces of thyroid hormone actions with blood coagulation and thrombosis. Clin Appl Thromb Hemost 2018; 24 (7): 1014–9. DOI: 10.1177/1076029618774150

14. Lania A, Sandri MT, Cellini M et al. Thyrotoxicosis in patients with COVID-19: The THYRCOV study. Eur. J. Endocrinol 2020; 183 (4): 381–7. DOI: 10.1530/EJE-20-0335

15. Wang W, Su X, Ding Y et al. Thyroid function abnormalities in COVID-19 patients. Front. Endocrinol 2021; 11: 623792. DOI: 10.3389/fendo.2020.623792

16. Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19. J Endocrinol Invest 2020; 43 (10): 1527–8. DOI: 10.1007/s40618-020-01366-7

17. Álvarez Martín MC, del Peso Gilsanz C, Hernández López A. Tiroiditis subaguda De Quervain tras infección por SARS-CoV-2. Endocrinol Diabetes y Nutr 2021; 68 (10): 754. DOI: 10.1016/j.endinu.2020.10.003

18. Asfuroglu Kalkan E, Ates I. A case of subacute thyroiditis associated with COVID-19 infection. J Endocrinol Invest 2020; 43 (8): 1173–4. DOI: 10.1007/s40618-020-01316-3

19. Brancatella A, Ricci D, Cappellani D et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. J Clin Endocrinol Metab. 2020; 105 (10): dgaa537. DOI: 10.1210/clinem/dgaa537

20. Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute thyroiditis associated with COVID-19. Case Rep Endocrinol 2020; 2020: 8891539. DOI: 10.1155/2020/8891539

21. Chong WH, Shkolnik B, Saha B, Beegle S. Subacute Thyroiditis in the Setting of Coronavirus Disease 2019. Am J Med Sci 2021; 361 (3): 400−2. DOI: 10.1016/j.amjms.2020.09.011

22. Mattar SAM, Quan Koh SJ, Chandran SR. et al. Subacute thyroiditis associated with COVID-19. BMJ Case Rep 2020; 13 (8): e237336. DOI: 10.1136/bcr-2020-237336

23. Mehmood MA, Bapna M, Arshad M. A case of post-COVID-19 subacute thyroiditis. Cureus 2020; 12 (12): e12301. DOI: 10.7759/ cureus.12301

24. Ruano R, Zorzano-Martinez M, Campos A et al. Subacute thyroiditis might be a complication triggered by SARS-CoV-2. Endocrinol Diabetes y Nutr 2021; 68 (10): 755−6. DOI: 10.1016/j.endinu.2020.09.002

25. Ruggeri RM, Campennì A, Siracusa M et al. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormes (Athens) 2021; 20 (1): 219–21. DOI: 10.1007/s42000-020-00230-w

26. San Juan MDJ, Florencio MQV, Joven MH. Subacute thyroiditis in a patient with coronavirus disease 2019. AACE Clin Case Rep 2020; 6 (6): e361–4. DOI: 10.4158/ACCR-2020-0524

27. Ippolito S, Dentali F, Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest 2020; 43 (8): 1171–2. DOI: 10.1007/s40618-020-01312-7

28. Barahona San Millán R, Tantinyà Daura M, Hurtado Ganoza A, Recasens Sala M. Painless thyroiditis in SARS-CoV-2 infection. Endocrinol Diabetes y Nutr (English ed) 2021; 68 (10): 757–8. DOI: 10.1016/j.endien.2021.11.030

29. Hanley B, Naresh KN, Roufosse C et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. The Lancet Microbe 2020; 1 (6): e245–53. DOI: 10.1016/S2666-5247(20)30115-4